Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...

The CBGM sensor lead was placed intravascularly via a percutaneous ... Forward-Looking Statements This news release contains forward-looking statements within the meaning of the Private Securities ...

The CBGM sensor lead was placed intravascularly via a percutaneous ... Forward-Looking Statements This news release contains forward-looking statements within the meaning of the Private Securities ...

Glucotrack’s CBGM is a long-term ... This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained ...

Both “pan” and “omni” mean “all,” and the distinction between omnisexuality and pansexuality is hazy. Some people use them interchangeably. Bisexuality, at its core, involves ...

Glucotrack’s CBGM is a long-term, implantable system that continually ... Forward-Looking Statements This news release contains forward-looking statements within the meaning of the Private Securities ...

For more information about Glucotrack’s CBGM, visit glucotrack.com. Information on the Company’s website does not constitute a part of and is not incorporated by reference into this press release.

Meghan Markle has been described as acting 'like a Mean Girls teenager' and becoming 'cold' towards staff in a damning profile in Vanity Fair. The Duchess of Sussex would reportedly be 'warm and ...

Meghan Markle has been dubbed a “‘Mean Girls’ teenager” by a former staffer who made new allegations in a bombshell exposé on the duchess and her husband, Prince Harry. The report ...

“I am honored to join the Company at this pivotal time as we advance our human clinical trials and create a strategic regulatory program for the Continuous Blood Glucose Monitor (CBGM),” said ...

"I am honored to join the Company at this pivotal time as we advance our human clinical trials and create a strategic regulatory program for the CBGM," Williams stated regarding his new role at ...

“I am honored to join the Company at this pivotal time as we advance our human clinical trials and create a strategic regulatory program for the Continuous Blood Glucose Monitor (CBGM),” said Mr.